Literature DB >> 9520014

A prospective study of cognitive function and onset of dementia in cognitively healthy elders.

E H Rubin1, M Storandt, J P Miller, D A Kinscherf, E A Grant, J C Morris, L Berg.   

Abstract

OBJECTIVE: To examine the earliest cognitive changes associated with the onset of dementia as well as changes associated with normal aging.
DESIGN: Longitudinal evaluation of participants with annual clinical and psychometric examinations for up to 15 1/2 years. SETTING AND PARTICIPANTS: Elderly volunteers (n = 82) enrolled with a Clinical Dementia Rating of 0 (cognitively intact) in longitudinal studies.
INTERVENTIONS: None. MAIN OUTCOME MEASURES: Clinical Dementia Rating and results of a 1 1/2-hour psychometric battery.
RESULTS: As estimated with survival analysis, 40% of participants had a Clinical Dementia Rating greater than 0 (cognitive decline) within 12 years of enrollment; 59% of these were judged to have dementia of the Alzheimer type or incipient dementia. Participants with poorer performance on psychometric testing at enrollment were at higher risk for cognitive decline subsequently. The rate of change in psychometric performance before clinically detectable cognitive change occurred was not significantly different between those who eventually developed dementia and those who remained stable, except for performance on the Logical Memory subtest of the Wechsler Memory Scale. When subtle cognitive decline was clinically detected, however, an abrupt deterioration in performance on independently administered psychometric tests was observed.
CONCLUSIONS: Cognitively healthy elderly people maintain stable cognitive performance when measured longitudinally by both careful clinical evaluation and repeated psychometric testing. This stability is maintained unless and until they develop a dementing illness, at which time a sharp decline in performance is observed.

Entities:  

Mesh:

Year:  1998        PMID: 9520014     DOI: 10.1001/archneur.55.3.395

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  78 in total

Review 1.  Changes in cognition.

Authors:  Marilyn S Albert
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

2.  Abnormal verbal event related potentials in mild cognitive impairment and incipient Alzheimer's disease.

Authors:  J M Olichney; S K Morris; C Ochoa; D P Salmon; L J Thal; M Kutas; V J Iragui
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

3.  Effects of healthy aging and early stage dementia of the Alzheimer's type on components of response time distributions in three attention tasks.

Authors:  Chi-Shing Tse; David A Balota; Melvin J Yap; Janet M Duchek; David P McCabe
Journal:  Neuropsychology       Date:  2010-05       Impact factor: 3.295

4.  Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.

Authors:  Montserrat Alegret; Gemma Cuberas-Borrós; Ana Espinosa; Sergi Valero; Isabel Hernández; Agustín Ruíz; James T Becker; Maitée Rosende-Roca; Ana Mauleón; Oscar Sotolongo; Joan Castell-Conesa; Isabel Roca; Lluís Tárraga; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 5.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

6.  Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

Authors:  B C Dickerson; T R Stoub; R C Shah; R A Sperling; R J Killiany; M S Albert; B T Hyman; D Blacker; L Detoledo-Morrell
Journal:  Neurology       Date:  2011-04-13       Impact factor: 9.910

7.  The Extensible Neuroimaging Archive Toolkit: an informatics platform for managing, exploring, and sharing neuroimaging data.

Authors:  Daniel S Marcus; Timothy R Olsen; Mohana Ramaratnam; Randy L Buckner
Journal:  Neuroinformatics       Date:  2007

Review 8.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

9.  Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.

Authors:  P Hemachandra Reddy; M Flint Beal
Journal:  Trends Mol Med       Date:  2008-01-22       Impact factor: 11.951

10.  Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful.

Authors:  J Tian; R S Bucks; J Haworth; G Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.